These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3335168)

  • 1. Safety and efficacy of amiodarone. The low-dose perspective.
    Kowey PR; Friehling TD; Marinchak RA; Sulpizi AM; Stohler JL
    Chest; 1988 Jan; 93(1):54-9. PubMed ID: 3335168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
    Vietti-Ramus G; Veglio F; Marchisio U; Burzio P; Latini R
    Int J Cardiol; 1992 Apr; 35(1):77-85. PubMed ID: 1563883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone.
    Mostow ND; Vrobel TR; Noon D; Rakita L
    Am Heart J; 1990 Dec; 120(6 Pt 1):1356-63. PubMed ID: 2248182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
    Page RL; Pritchett EL; Connolly S; Wilkinson WE;
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone in the nineties: to whom and what dosage?].
    Moro Serrano C; Hernández Madrid A; Lage Silveira J; Vivas Alvarez E; Kanjhi M
    Rev Esp Cardiol; 1995 Apr; 48(4):272-84. PubMed ID: 7740149
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of cordarone as an antiarrhythmic agent.
    Piwowarska W; Sniezek-Maciejewska M
    Cor Vasa; 1987; 29(4):269-77. PubMed ID: 2445525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antiarrhythmic drugs in pediatric use: amiodarone.
    Paul T; Guccione P
    Pediatr Cardiol; 1994; 15(3):132-8. PubMed ID: 8047495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
    Hohnloser SH; Meinertz T; Dammbacher T; Steiert K; Jähnchen E; Zehender M; Fraedrich G; Just H
    Am Heart J; 1991 Jan; 121(1 Pt 1):89-95. PubMed ID: 1985383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.